MD663G2 - Derivatives of erythromycin, methods for their preparation and use as medicines - Google Patents

Derivatives of erythromycin, methods for their preparation and use as medicines

Info

Publication number
MD663G2
MD663G2 MD95-0431A MD950431A MD663G2 MD 663 G2 MD663 G2 MD 663G2 MD 950431 A MD950431 A MD 950431A MD 663 G2 MD663 G2 MD 663G2
Authority
MD
Moldova
Prior art keywords
compounds
heteroatoms
formula
saturated
possibly
Prior art date
Application number
MD95-0431A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD663F1 (en
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel Uclaf, Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf, Societe Anonyme filed Critical Roussel Uclaf, Societe Anonyme
Publication of MD663F1 publication Critical patent/MD663F1/en
Publication of MD663G2 publication Critical patent/MD663G2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compuşii cu formula generală (I):în care fie că R1 şi R2, care sunt identici sau diferiţi, reprezintă atom de hidrogen sau radical de hidrocarbură, saturat sau nesaturat, conţinând până la 24 atomi de carbon, fiind eventual întrerupt prin unul sau mai mulţi heteroatomi şi având una sau mai multe grupări funcţionale; fie că R1 şi R2, împreună cu atomul de azot, cuplat cu ei, formează un inel heterociclic, ce conţine eventual unul sau mai mulţi heteroatomi, selectaţi dintre azot, oxigen sau sulf; fie că R1 şi R2, luaţi împreună, formează un radical (a), în care R'1 şi R'2, care sunt identici sau diferiţi, reprezintă atom de hidrogen sau radical de hidrocarbură, saturat sau nesaturat, conţinând până la 23 atomi de carbon, fiind eventual întrerupt prin unul sau mai mulţi heteroatomi şi conţinând una sau mai multe grupări funcţionale, şi Z reprezintă un atom de hidrogen sau un rest de acid carboxilic, conţinând până la 18 atomi de carbon, precum şi sărurile lor aditive cu acizii compuşilor cu formula (I). Compuşii cu formula (I) posedă proprietăţi antibiotice valoroase.Compounds of general formula (I): wherein either R 1 and R 2, which are the same or different, represent a saturated or unsaturated hydrogen or hydrocarbon radical containing up to 24 carbon atoms, possibly interrupted by one or more many heteroatoms and having one or more functional groups; or that R 1 and R 2, together with the nitrogen atom, coupled thereto, form a heterocyclic ring, possibly containing one or more heteroatoms, selected from nitrogen, oxygen or sulfur; either R 1 and R 2, taken together, form a radical (a), wherein R 1 and R 2, which are the same or different, represent a saturated or unsaturated hydrogen atom or hydrocarbon radical containing up to 23 atoms. of carbon, possibly interrupted by one or more heteroatoms and containing one or more functional groups, and Z represents a hydrogen atom or a carboxylic acid moiety, containing up to 18 carbon atoms, as well as their additive salts with acids. of compounds of formula (I). The compounds of formula (I) possess valuable antibiotic properties.

MD95-0431A 1994-04-08 1995-04-06 Derivatives of erythromycin, methods for their preparation and use as medicines MD663G2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (en) 1994-04-08 1994-04-08 New erythromycin derivatives, their preparation process and their use as drugs.
PCT/FR1995/000441 WO1995027720A1 (en) 1994-04-08 1995-04-06 Novel erythromycin derivatives, method for preparing same and use thereof as drugs

Publications (2)

Publication Number Publication Date
MD663F1 MD663F1 (en) 1997-01-31
MD663G2 true MD663G2 (en) 1997-07-31

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0431A MD663G2 (en) 1994-04-08 1995-04-06 Derivatives of erythromycin, methods for their preparation and use as medicines

Country Status (49)

Country Link
US (2) US5656607A (en)
EP (1) EP0676409B1 (en)
JP (1) JP3000023B2 (en)
KR (1) KR100317148B1 (en)
CN (1) CN1059445C (en)
AP (1) AP587A (en)
AT (1) ATE234853T1 (en)
AU (1) AU684939B2 (en)
BG (1) BG61916B1 (en)
BR (1) BR9506147A (en)
CA (1) CA2164638C (en)
CO (1) CO4370097A1 (en)
CZ (1) CZ296005B6 (en)
DE (1) DE69529934T2 (en)
DK (1) DK0676409T3 (en)
DZ (1) DZ1869A1 (en)
EE (1) EE04498B1 (en)
ES (1) ES2189820T3 (en)
FI (1) FI111264B (en)
FR (1) FR2718450B1 (en)
GB (1) GB2288174A (en)
GE (1) GEP19991836B (en)
HR (1) HRP950217B1 (en)
HU (1) HU215396B (en)
IL (1) IL112954A (en)
IS (1) IS1865B (en)
JO (1) JO1850B1 (en)
LV (1) LV11182B (en)
MA (1) MA23501A1 (en)
MD (1) MD663G2 (en)
MY (1) MY114672A (en)
NO (1) NO308361B1 (en)
NZ (1) NZ284498A (en)
OA (1) OA10200A (en)
PE (1) PE2896A1 (en)
PL (1) PL180837B1 (en)
PT (1) PT676409E (en)
RO (1) RO115634B1 (en)
RU (1) RU2141965C1 (en)
SA (1) SA97170757A (en)
SI (1) SI0676409T1 (en)
SK (1) SK284079B6 (en)
SV (1) SV1995000018A (en)
TN (1) TNSN95026A1 (en)
TW (1) TW316908B (en)
UA (1) UA44705C2 (en)
WO (1) WO1995027720A1 (en)
YU (1) YU49221B (en)
ZA (1) ZA952059B (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (en) * 1995-03-22 1997-04-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2742757B1 (en) 1995-12-22 1998-01-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2745289B1 (en) * 1996-02-28 1998-05-29 Roussel Uclaf NOVEL DERIVATIVES OF CARBOXYLIC ACID 1 (2H) QUINOLEIN, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION TO THE SYNTHESIS OF PRODUCTS WITH ANTIBIOTIC PROPERTIES
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
PT922050E (en) * 1996-05-07 2003-12-31 Abbott Lab 3-DESCLADINOSE-2,3-ANYDROERITROMYCIN DERIVATIVES
FR2748746B1 (en) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc NEW PROCESS FOR ISOMERIZATION OF RADICAL METHYL IN 10 FROM ERYTHROMYCIN DERIVATIVES
FR2751656B1 (en) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
ATE296831T1 (en) * 1996-09-04 2005-06-15 Abbott Lab 6-0-SUBSTITUTED KETOLIDES WITH ANTIBACTERIAL ACTION
UA51730C2 (en) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-0-substituted ketolides having antibacterial activity
FR2757168B1 (en) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2760017B1 (en) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc NOVEL ERYTROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (en) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (en) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc USE OF KETOLIDES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS LINKED TO ATHEROSCLEROSIS
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
AU5299499A (en) 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1137654A1 (en) 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (en) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
JP2002542197A (en) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Ketolide antibacterial agent
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
TR200103395T2 (en) * 1999-05-24 2002-04-22 Pfizer Products Inc. 13-methyl erythromycin derivatives.
JP4509553B2 (en) 2001-07-03 2010-07-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド C12-modified erythromycin macrolide and ketolide having antibacterial activity
KR101035043B1 (en) 2002-07-01 2011-05-19 아르키온 라이프 사이언씨즈 엘엘씨 Materials and Processes for the Preparation of Glucosamine and N-acetylglucosamine
EP3738591A3 (en) * 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
CA2523134A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
CN101917850B (en) 2007-10-25 2016-01-13 森普拉制药公司 Preparation method of macrolide antibacterial agent
DK2358379T3 (en) * 2008-10-24 2016-03-07 Cempra Pharmaceuticals Inc BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
BR112012023950A2 (en) 2010-03-22 2016-07-05 Cempra Pharmaceuticals Inc crystalline forms of a macrolide, and uses thereof
PL2571506T3 (en) 2010-05-20 2017-10-31 Cempra Pharmaceuticals Inc Processes for preparing macrolides and ketolides and intermediates therefor
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
MX2014011537A (en) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics.
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
BR112015023670A2 (en) 2013-03-15 2017-07-18 Cempra Pharmaceuticals Inc process for preparing a compound
BR112015025159A2 (en) 2013-04-04 2017-07-18 Harvard College macrolides and methods for their preparation and use
HK1242920A1 (en) * 2014-10-08 2018-07-06 哈佛大学的校长及成员们 14-membered ketolides and methods of their preparation and use
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (en) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Process for treating planting material of flowers before planting
JP7199722B2 (en) 2019-12-25 2023-01-06 旭精工株式会社 Coin transport sorting mechanism and coin identification transport device provided with the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0596802A1 (en) * 1992-11-05 1994-05-11 Roussel Uclaf Erythromycin derivatives, their process of preparation and their application as medicaments

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (en) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K PROCESS FOR PRODUCING NEW ERYTHROMYCINE DERIVATIVES
DE2842759A1 (en) * 1978-09-30 1980-04-10 Merck Patent Gmbh BASIC AETHER, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND METHOD FOR THE PRODUCTION THEREOF
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (en) * 1992-06-19 1995-06-02 Roussel Uclaf New picromycin derivatives, their preparation process and their use as medicines.
FR2697524B1 (en) * 1992-11-05 1994-12-23 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (en) * 1993-03-09 1995-04-28 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0596802A1 (en) * 1992-11-05 1994-05-11 Roussel Uclaf Erythromycin derivatives, their process of preparation and their application as medicaments

Also Published As

Publication number Publication date
EE04498B1 (en) 2005-06-15
JP3000023B2 (en) 2000-01-17
IL112954A (en) 2000-07-16
WO1995027720A1 (en) 1995-10-19
FR2718450A1 (en) 1995-10-13
RU2141965C1 (en) 1999-11-27
DZ1869A1 (en) 2002-02-17
DE69529934T2 (en) 2003-09-04
ZA952059B (en) 1996-03-13
UA44705C2 (en) 2002-03-15
HU9503505D0 (en) 1996-02-28
SA97170757A (en) 2005-12-03
ES2189820T3 (en) 2003-07-16
MA23501A1 (en) 1995-12-31
SK154695A3 (en) 1996-10-02
CN1059445C (en) 2000-12-13
CA2164638C (en) 2003-12-30
NO954942L (en) 1996-02-07
PT676409E (en) 2003-08-29
PL180837B1 (en) 2001-04-30
BR9506147A (en) 1996-04-16
CN1126997A (en) 1996-07-17
AP587A (en) 1997-04-29
US5656607A (en) 1997-08-12
FR2718450B1 (en) 1997-01-10
GEP19991836B (en) 1999-11-05
FI955913A7 (en) 1995-12-08
DE69529934D1 (en) 2003-04-24
BG100150A (en) 1996-06-28
HUT73772A (en) 1996-09-30
GB9506856D0 (en) 1995-05-24
SK284079B6 (en) 2004-09-08
IS1865B (en) 2003-05-02
FI955913A0 (en) 1995-12-08
CO4370097A1 (en) 1996-10-07
NO308361B1 (en) 2000-09-04
SI0676409T1 (en) 2003-06-30
RO115634B1 (en) 2000-04-28
IL112954A0 (en) 1995-06-29
HRP950217A2 (en) 1997-08-31
YU49221B (en) 2004-11-25
FI111264B (en) 2003-06-30
CZ322395A3 (en) 1996-08-14
MD663F1 (en) 1997-01-31
EE9500080A (en) 1996-12-16
TNSN95026A1 (en) 1996-02-06
NO954942D0 (en) 1995-12-06
HRP950217B1 (en) 2004-06-30
AU684939B2 (en) 1998-01-08
AU2310795A (en) 1995-10-30
EP0676409B1 (en) 2003-03-19
JO1850B1 (en) 1995-12-27
PE2896A1 (en) 1996-02-12
MY114672A (en) 2002-12-31
LV11182A (en) 1996-04-20
AP9500743A0 (en) 1995-07-31
ATE234853T1 (en) 2003-04-15
CA2164638A1 (en) 1995-10-19
CZ296005B6 (en) 2005-12-14
GB2288174A (en) 1995-10-11
BG61916B1 (en) 1998-09-30
IS4309A (en) 1995-11-17
DK0676409T3 (en) 2003-06-23
KR100317148B1 (en) 2002-06-22
YU21695A (en) 1997-12-05
LV11182B (en) 1997-04-20
OA10200A (en) 1996-12-18
NZ284498A (en) 1997-07-27
EP0676409A1 (en) 1995-10-11
TW316908B (en) 1997-10-01
JPH07278177A (en) 1995-10-24
PL311871A1 (en) 1996-03-18
US5760233A (en) 1998-06-02
HU215396B (en) 1998-12-28
SV1995000018A (en) 1997-10-24

Similar Documents

Publication Publication Date Title
MD663G2 (en) Derivatives of erythromycin, methods for their preparation and use as medicines
RO115159B1 (en) Piperazine derivatives and compositions containing the same
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
KR910007935A (en) Cyclocarbapenem Compound
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
RO78870B (en) PROCESS FOR THE PREPARATION OF MERCAPTOACILPROLINE DERIVATIVES
DE3750443D1 (en) Cephalosporin compounds, process for their preparation and antibacterial agents.
RU98105684A (en) PIPERASIN DERIVATIVES AND METHOD FOR PRODUCING THEM
RO82962B (en) PROCESS FOR THE PREPARATION OF CERTAIN DERIVATIVES OF CEFALOSPORINE
GB2248616B (en) Piperazine derivatives
IT1313571B1 (en) PROCEDURE FOR THE PREPARATION OF OLEFINIC OXIDES.
AU576887B2 (en) 1,6-naphthyridine derivatives
IT1230595B (en) IMMEDIATE PEROXYCID DERIVATIVES
ES8602775A1 (en) PROCEDURE TO PHOTOSTABILIZE MOLSIDOMINE
KR890000478A (en) Ergoline derivatives
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
GEP19970835B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
KR920002613A (en) Bicyclic sulfur compounds
ES433957A1 (en) Novel phenothiazines
GB1413255A (en) Acyloxyalkylpyrrolidine derivatives
GEP19970838B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
ES8307812A1 (en) Beta-lactam antibacterial agents, their preparation and use.

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20150406

MM4A Patent for invention definitely lapsed due to non-payment of fees